PAPER Scarpini E, Bruno G, Zappalà G, Adami M, Richarz U, Gaudig M, Jacobs A, Schäuble B
SEARCH RESULTS
331202 RESULTS
PAPER Koch G, Esposito Z, Kusayanagi H, Monteleone F, Codecá C, Di Lorenzo F, Caltagirone C, Bernardi G, Martorana A
CSF tau levels influence cortical plasticity in Alzheimer's disease patients.
J Alzheimers Dis. 2011;26(1):181-6. PubMed: 21606570PAPER Alexopoulos P, Richter-Schmidinger T, Horn M, Maus S, Reichel M, Sidiropoulos C, Rhein C, Lewczuk P, Doerfler A, Kornhuber J
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
J Alzheimers Dis. 2011;26(2):207-10. PubMed: 21606569PAPER Franceschi M, Caffarra P, Savarè R, Cerutti R, Grossi E,
Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer's disease.
Behav Neurol. 2011 Jan 1;24(2):149-58. PubMed: 21606576PAPER Hashimoto M, Hossain S
Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
J Pharmacol Sci. 2011;116(2):150-62. PubMed: 21606627PAPER Buchman AS, Boyle PA, Leurgans SE, Barnes LL, Bennett DA
Cognitive function is associated with the development of mobility impairments in community-dwelling elders.
Am J Geriatr Psychiatry. 2011 Jun;19(6):571-80. PubMed: 21606900PAPER Saraf MK, Prabhakar S, Khanduja KL, Anand A
Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice.
Evid Based Complement Alternat Med. 2011;2011:236186. PubMed: 21607013PAPER Sodhi RK, Singh N, Jaggi AS
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):115-24. PubMed: 21607645PAPER Ferlazzo N, Gorgone G, Caccamo D, Currò M, Condello S, Pisani F, Vernieri F, Rossini PM, Ientile R
The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.
Neuromolecular Med. 2011 Sep;13(3):167-74. PubMed: 21607713PAPER Fleck D, Garratt AN, Haass C, Willem M
BACE1 Dependent Neuregulin Proteolysis.
Curr Alzheimer Res. 2011 May 23; PubMed: 21605034PAPER Navarrete LP, Pérez P, Morales I, Maccioni RB
Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Curr Alzheimer Res. 2011 Sep 1;8(6):678-85. PubMed: 21605038PAPER Lasagna-Reeves CA, Castillo-Carranza DL, Jackson GR, Kayed R
Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.
Curr Alzheimer Res. 2011 Sep 1;8(6):659-65. PubMed: 21605039PAPER Bonda DJ, Castellani RJ, Zhu X, Nunomura A, Lee HG, Perry G, Smith MA
A novel perspective on tau in Alzheimer's disease.
Curr Alzheimer Res. 2011 Sep 1;8(6):639-42. PubMed: 21605042PAPER Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmercières J, Troquier L, Brouillette J, Tsambou L, Grosjean ME, Caillierez R, Demeyer D, Hamdane M, Schindowski K, Blum D, Buée L
Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?
Curr Alzheimer Res. 2011 Sep 1;8(6):633-8. PubMed: 21605043PAPER Rudrabhatla P, Pant HC
Role of Protein Phosphatase 2A in Alzheimer's Disease.
Curr Alzheimer Res. 2011 Sep 1;8(6):623-32. PubMed: 21605044Current Filters
No filters selected